Reality beat their plan and they're leaning in: recent realized upside surprise, response underway, drivers still live
The model's full reasoning — Q4 2022 call → NOWe need to answer YES or NO based on the transcript. The question asks: On this call, does management recount that something REAL in the recent period turned out BETTER THAN THE COMPANY ITSELF HAD EXPECTED OR PLANNED — and is the company ALREADY responding to that favorable surprise in some visible way, with the cause of the surprise described as still in effect rather than finished? We need to find if management indicates a realized favorable surprise, a response already visible, and the cause still running. Let's scan the transcript for phrases like "ahead of expectations", "better than expected", "faster than planned", etc. In the opening remarks, Chris Anzalone says: "We have increased clarity as to the makeup of our multiple Phase 3 programs, increased clarity as to how we intend to use our late-stage drug candidates in different patient populations, increased clarity as to when we expect proof of concept from our earlier stage programs, increased clarity as to where we plan to go next with the expansion of our platforms into new cell types, increased clarity as to how large we think our pipeline of clinical candidates will be over the next few years and increased clarity about how we intend to finance our growing pipeline." That's about clarity, not necessarily a favorable surprise. Later, he says: "We have line of sight on timelines for initial interim clinical results for two of our pulmonary programs. James will give details on the status, but ARO-RAGE and ARO-MUC5AC are progressing well and we anticipate being able to provide interim data publicly in the first half of 2023. Should we have data that provides clinical proof of concept, I think this would be a potentially big de-risking event for the candidates, and for the pulmonary platform generally. We believe we’ve made a lot of progress with the platform since our generation one candidate ARO-ENaC, and gaining clarity on how the generation two candidates perform will be exciting." That's about progress, but not necessarily exceeding expectations. He also says: "Our discovery engine continues to perform and we expect to announce the next cell type we will be targeting in the first half of 2023." That's about future plans. Now, look for specific instances where management says something like "ahead of schedule" or "better than expected".
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SFIX | Stitch Fix, Inc. | Q3 2024 | 2024-06-04 | C+ |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| NC | NACCO Industries, Inc. | Q1 2024 | 2024-05-05 | C+ |
| CTRA | Coterra Energy Inc. | Q1 2024 | 2024-05-03 | A |
| CW | Curtiss-Wright Corporation | Q1 2024 | 2024-05-02 | B+ |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| MNKD | MannKind Corporation | Q4 2023 | 2024-02-27 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| GPRO | GoPro, Inc. | Q4 2023 | 2024-02-07 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| AEP | American Electric Power Company, Inc. | Q3 2023 | 2023-11-02 | C+ |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| ET | Energy Transfer LP | Q2 2023 | 2023-08-02 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| IT | Gartner, Inc. | Q2 2022 | 2022-08-02 | A |
| HLIO | Helios Technologies, Inc. | Q1 2022 | 2022-05-10 | C |
| CCRN | Cross Country Healthcare, Inc. | Q1 2022 | 2022-05-04 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| TJX | The TJX Companies, Inc. | Q2 2021 | 2021-08-18 | C |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| EMR | Emerson Electric Co. | Q3 2021 | 2021-08-04 | B+ |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| DGX | Quest Diagnostics Incorporated | Q2 2021 | 2021-07-22 | B+ |
| JPM | JPMorgan Chase & Co. | Q2 2021 | 2021-07-13 | A |
| CMTL | Comtech Telecommunications Corp. | Q1 2019 | 2018-12-07 | B+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| FOSL | Fossil Group, Inc. | Q1 2018 | 2018-05-08 | C |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| BIIB | Biogen Inc. | Q2 2017 | 2017-07-25 | B |
| TPB | Turning Point Brands, Inc. | Q1 2017 | 2017-05-11 | B |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| CGNX | Cognex Corporation | Q2 2016 | 2016-08-01 | A |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| SAN | Banco Santander, S.A. | Q4 2015 | 2016-01-27 | B |
TENB · Q2 2021 → YESThe question is about whether management recounts something real that turned out better than expected, and they're already responding to it, with the cause still in effect. YES The transcript shows management describing the Alsid acquisition as delivering a realized favorable surprise: customers and prospects received the identity and user permission vulnerability assessment "well received" and it led to "outperformance of our earlier expectations from the business." This concerns a real operating event (customer adoption and platform uptake) that already happened and exceeded the company's own prior expectations. Management is visibly responding by accelerating investments: they plan to continue adding quota capacity in the second half (more than in the first half) and to invest in sales and marketing, explicitly tied to the strong performance and confidence in the business.
CYBR · Q3 2021 → YESThe question is: Does management recount that something REAL in the recent period turned out BETTER THAN THE COMPANY ITSELF HAD EXPECTED OR PLANNED — and is the company ALREADY responding to that favo...YES Management describes a realized favorable surprise in the subscription transition: "we made strong progress and outperformed our expectations in the third quarter" and "subscription ARR growth accelerated to 131%," with "strong demand for our SaaS solutions" continuing to drive it. They are already responding visibly by accelerating the transition and realloc resources, resetting plans upward to exit by Q3 2022 instead of Q4, and raising the annual recurring revenue growth expectation from 35% to 37% based on record bookings. The cause remains in effect, as they note the acceleration and strong demand environment persisting into the year.
ET · Q2 2023 → YESThe question is: Does management recount that something REAL in the recent period turned out BETTER THAN THE COMPANY ITSELF HAD EXPECTED OR PLANNED — and is the company ALREADY responding to that favo...YES The transcript shows management describing a realized favorable surprise on the Enable acquisition: actual performance "exceed[s] anything that we ever expected," with results "significantly higher, a good probably 40% or 50% higher than what we were anticipating." They attribute part of the upside to ongoing commercial synergies being discovered daily as integration proceeds. Management is visibly responding by integrating the assets, actively identifying and implementing new commercial opportunities (new routes, blending, additions to move more throughput), and reallocating attention toward expanding volumes.